1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with rolipram in 17 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (rolipram) | Trials (rolipram) | Recent Studies (post-2010) (rolipram) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,604 | 17 | 401 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (64.71) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
Cortijo, J; Morcillo, EJ; Ortiz, JL; Vallés, JM | 1 |
Fletcher, JR; Noel, PE; Thompson, WJ | 1 |
Turner, NC; Wood, LJ | 1 |
Battram, CH; Jordan, R; Lewis, SA; Raeburn, D; Sharma, S; Souness, JE; Tomkinson, A; Underwood, SL; Webber, SE; Woodman, VR | 1 |
Bou, J; Cortijo, J; Morcillo, EJ; Ortiz, JL; Vallés, JM | 1 |
Cortijo, J; Martí-Cabrera, M; Morcillo, EJ; Ortiz, JL; Vallés, JM | 1 |
Church, MK; Hatzelmann, A; Schudt, C; Shute, JK; Tenor, H | 1 |
Alves, AC; Cordeiro, RS; Cruz, HN; Diaz, BL; Lagente, V; Martins, MA; Pires, AL; Serra, MF | 1 |
Berends, C; de Monchy, JG; Dijkhuizen, B; Dubois, AE; Gerritsen, J; Kauffman, HF | 1 |
Akuta, K; Manabe, H; Ohmori, K; Okamura, K | 1 |
Wise, H | 1 |
Dent, G; Djukanović, R; Hidi, R; Holgate, ST; Liu, E; Schudt, C; Timmermans, S | 1 |
Akuta, K; Kawasaki, H; Manabe, H; Ohmori, K | 1 |
Anderson, R; Steel, HC | 1 |
Anam, EM; Blázquez, MA; Cerdá-Nicolás, M; Cortijo, J; Estellés, R; Issekutz, AC; Ivorra, MD; López-Martín, J; Martínez-Losa, M; Milian, L; Morcillo, EJ; O'Connor, JE; Sanz, MJ | 1 |
Adamson, RH; Altangerel, A; Curry, FE; Drenckhahn, D; Lenz, JF; Ly, JC; Sarai, RK | 1 |
17 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and rolipram
Article | Year |
---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Rolipram inhibits PAF-induced airway microvascular leakage in guinea-pig: a comparison with milrinone and theophylline.
Topics: Animals; Capillary Permeability; Evans Blue; Guinea Pigs; Milrinone; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyridones; Pyrrolidinones; Respiratory System; Rolipram; Theophylline | 1992 |
Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance.
Topics: Animals; Capillary Permeability; Cyclic AMP; In Vitro Techniques; Isoproterenol; Lung; Male; Phosphodiesterase Inhibitors; Platelet Activating Factor; Protein Kinase C; Pyrrolidinones; Rats; Rolipram; Vascular Resistance | 1995 |
Superoxide generation by guinea-pig peritoneal macrophages is inhibited by rolipram, staurosporine and mepacrine in an agonist-dependent manner.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alkaloids; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Macrophages, Peritoneal; Male; N-Formylmethionine Leucyl-Phenylalanine; Phospholipases A; Phospholipases A2; Phosphoric Diester Hydrolases; Platelet Activating Factor; Protein Kinase C; Pyrrolidinones; Quinacrine; Respiratory Burst; Rolipram; Staurosporine; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
Topics: Albuterol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bronchial Hyperreactivity; Bronchial Spasm; Bronchodilator Agents; Capillary Permeability; Guinea Pigs; Hemodynamics; Histamine; Inflammation; Male; Muscle Contraction; Muscle, Smooth; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram | 1994 |
Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs.
Topics: Aminophylline; Animals; Blood Pressure; Bradykinin; Bronchi; Capillary Permeability; Drug Interactions; Evans Blue; Guinea Pigs; Histamine; Microcirculation; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rolipram; Trachea | 1993 |
Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.
Topics: Animals; Asthma; Dose-Response Relationship, Drug; Eosinophils; Guinea Pigs; Histamine; Male; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Respiratory System; Rolipram | 1996 |
Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bronchodilator Agents; Chemotaxis, Leukocyte; Complement C5a; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Activation; Eosinophils; Humans; Hypersensitivity, Immediate; In Vitro Techniques; Leukotriene C4; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rolipram; Theophylline | 1996 |
Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Topics: Adrenergic beta-Agonists; Animals; Bucladesine; Chemotaxis, Leukocyte; Colforsin; Cyclic AMP; Eosinophils; Isoenzymes; Leukotriene B4; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Aggregation; Pyrrolidinones; Rats; Rats, Wistar; Rolipram | 1996 |
Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram.
Topics: Bucladesine; CD11 Antigens; Dinoprostone; Eosinophils; Flow Cytometry; Humans; Isoproterenol; L-Selectin; Neutrophils; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rolipram | 1997 |
KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Acetylcholine; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Electric Stimulation; Eosinophils; Guinea Pigs; Muscle Contraction; Muscle, Smooth; Naphthyridines; Neurokinin A; Neutrophils; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Activating Factor; Pyrrolidinones; Respiratory Therapy; Rolipram; Substance P | 1997 |
Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation.
Topics: Animals; Biphenyl Compounds; Cell Aggregation; Cyclic AMP; Dinoprostone; Epoprostenol; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Rolipram | 1998 |
Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis.
Topics: Albuterol; Asthma; Bucladesine; Chemotaxis, Leukocyte; Colforsin; Cyclic AMP; Humans; Interleukin-8; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Activating Factor; Rolipram; T-Lymphocytes; Theophylline | 2000 |
The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs.
Topics: Acetylcholine; Administration, Inhalation; Airway Resistance; Aminophylline; Animals; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Disease Models, Animal; Eosinophils; Guinea Pigs; Male; Naphthyridines; Phosphodiesterase Inhibitors; Platelet Activating Factor; Pneumonia; Rolipram; Specific Pathogen-Free Organisms; Vasodilator Agents | 2000 |
Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenylyl Cyclases; Bucladesine; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytosol; Homeostasis; Humans; In Vitro Techniques; Leukocyte Elastase; Luminescent Measurements; Membrane Potentials; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Membrane Glycoproteins; Purinergic P1 Receptor Agonists; Radioimmunoassay; Receptor, Adenosine A2A; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Rolipram; Spectrometry, Fluorescence; Superoxides | 2002 |
Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
Topics: Adenosine Monophosphate; Alkaloids; Animals; Calcium; Cell Communication; Cell Line; Colforsin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Leukocyte Rolling; Leukocytes; Male; Microscopy, Video; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenanthrenes; Plant Extracts; Platelet Activating Factor; Protein Binding; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rolipram | 2003 |
Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery.
Topics: Adrenergic beta-Agonists; Animals; Cadherins; Capillary Permeability; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Indicators and Reagents; Isoproterenol; Male; Microscopy, Confocal; Phosphodiesterase Inhibitors; Platelet Activating Factor; rap1 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Splanchnic Circulation | 2008 |